Sponsorship ProspectusCell & Gene Meeting on the MesaOctober 3-5, 2018La Jolla, CA

13th Annual Scientific Symposium8th Annual Partnering Forum

www.meetingonthemesa.com

The Cell & Gene Meeting on the Mesa is a three-day conference bringing together senior executives and topdecision-makers in the industry with the scientific community to advance cutting-edge research into cures.The meeting features a nationally recognized Scientific Symposium, attended by leading researchers andclinical experts from around the globe, in conjunction with the industry’s premier annual Partnering Forum,the first event of its kind dedicated solely to facilitating connections in this sector. Combined, these meetingsattract over 950 attendees, fostering key partnerships through more than 1,450 one-on-one meetings whilehighlighting the significant clinical and commercial progress in the field.

Conference Overview

Who Attends?

Day One (Estancia - Oct. 3): Partnering Forum• Featured Plenary Session• Interactive Workshops• In-Depth Panel Discussions• Company Presentations• One-On-One Partnering• Gala Reception

Agenda at a Glance

• 970+ attendees over the course of the three-day conference• 1,450+ one-on-one meetings scheduled throughout the Partnering Forum using a state-of-the-art

partnering system to match and connect participants with prospective partners and investors• 90+ speakers and panelists covering topics from market access strategies to the discoveries in gene editing• 70+ presentations by the field’s most prominent publicly traded and emerging private companies• 35+ scientific posters highlighting cutting-edge research from labs throughout the country on display• 10+ interactive panels addressing critical commercial, scientific, regulatory and reimbursement issues• Zero reasons to miss the 2018 meeting!

Highlights by the Numbers

415Companies

200+C-Level Attendees

1,4501x1 Meetings

950Attendees

C-Level/President21%

Director17%

Vice President11%

Manager/Associate11%

Student9%

Scientist9%

Head/Leader4%

Professor3%

EVP/Executive3%

Consultant/Advisor2%

GM/Managing Director

2%

Partner/Principal1%

Media1%

Other/Misc.6%

Day Two (Estancia - Oct. 4):Partnering Forum• Interactive Workshops• In-Depth Panel Discussions• Company Presentations• One-On-One Partnering• Public Forum & Reception

Day Three (Salk Institute - Oct. 5):Scientific Symposium • Keynote Talks• Scientific Panel Discussions• All-day Poster Viewing• Closing Networking Reception

Attendee Breakdown by Title• C-Level/President: 21%• Director: 17%• Vice President: 11%• Manager/Associate: 11%• Student: 9%• Scientist: 9%• Head/Leader: 4%• Professor: 3%• EVP/Executive: 3%• Consultant/Advisor: 2%• GM/Managing Director: 2%• Partner/Principal: 1%• Media: 1%• Other/Misc.: 6%

2017 Attending Organizations4D Molecular Therapeutics, AABB, Abeona Therapeutics, ACF Bioservices, Acucela, Adage Capital Management, Adaptimmune, Adjuvant Partners, Adverum Biotechnologies, Aegle Therapeutics Corporation, AGTC, Ajinomoto, Akron Biotech, Aldevron, Alira Health, All India Institute of Medical Sciences, AllCells, Allele Biotechnology & Pharmaceuticals, Allergan, Alliance for Regenerative Medicine, AlloSource, American Gene Technologies, American Society for Blood and Marrow Transplantation, American Society of Gene & Cell Therapy, Amnion Foundation, Anthem, AskBio, Astellas Pharma, Asterias Biotherapeutics, Atara Biotherapeutics, Ather-sys, Audentes Therapeutics, Avectas, Avery Therapeutics, AveXis, AVM Biotechnology, AVROBIO, AxoGen, Bank of America Merrill Lynch, Baylor College of Medicine, BD Biosciences, Be the Match BioTherapies, Beaux Surgery, Beijing Genomics Institute, Bell Biosystems, Bellicum Pharmaceuticals, Benitec Biopharma, Berlin-Brandenburg Center for Regenerative Therapies, BioBridge Global, BioInsights Publishing, BioLife Solutions, Biological Industries USA, BioMarin Pharmaceutical, BioMedGPS, bioMerieux, Bioreclama-tionIVT, Biostage, Bio-Techne, BioTime, Blood Systems, BloodCenter of Wisconsin, Bloodworks, bluebird bio, BlueRock Therapeutics, B-MoGen Biotechnologies, Bone Therapeutics, Boston Biomedical Associates, Boston Scientific, BOUNDLESS Regenerative, BrainXell, Brammer Bio, BridgeBio Pharma, Brooks Life Science Systems, Buck Institute for Research on Aging, Cal Poly San Luis Obispo, Caladri-us Biosciences, California Department of Public Health, California Institute for Biomedical Research, Canale Communications, Capricor Therapeutics, CARsgen Therapeutics, CarthaGenetics Suisse Sàrl, Casdin Capital, Catalyst Advisors, Catalyst Healthcare Consulting, CCRM, Cell and Gene Therapy Catapult, Cell Innovation Partners, Cell Medica, Cell Therapies Pty., Cell Therapy Interna-tional, CellGenix, Cells for Cells – Universidad de Los Andes, CellSeed, Cellular Dynamics International, Celsense, Cesca Therapeutics, Charter Medical, Children’s Hospital Los Angeles, Chromocenter, CIRM, City of Hope, CJ Partners, ClearView Healthcare Partners, Cleveland Clinic, CMIC Holdings, Cognate Bioservices, College of Engineering, Pune, CombiGene, Compass Biomedical, Consulate General of France, Cook Regentec, Covance, CRISPR Therapeutics, Cryoport, CSL Behring, CSU San Marcos, CTI Clinical Trial and Consulting Services, Cynata Therapeutics, Cynity, Cytonome, D&P Bioinnovations, Danaher, DavisTrapp, Defined Health, DEFTA Partners, Department of Commerce, Diamond Pharma Services, Dignity Health, DiscGenics, Dohmen Life Science Services, Dorsey, Draper, EBD Group, Editas Medicine, EMD Millipore, Enzyvant, ERA Consulting UK, EUFETS, Evercore ISI, Evidera, a PPD company, Faegre Baker Daniels, Fate Therapeutics, Fibrocell Science, Forum for Innovative Regenerative Medicine (FIRM), Fisher BioServices, Flodesign Sonics, Fortress Biotech, F-Prime Capital, Fraunhofer Institute of Cell Therapy and Immunology, Fred Hutchinson Cancer Research Center, FreeMind Group, Fresenius Kabi USA, GammaDelta Therapeutics, GE Healthcare, GenCure, Genea Biocells, GenEdit, George Washington University, GlaxoSmithKline, Global Genes, Global Stem Cells and Regenerative Medicine Acceleration Center (GSRAC), Glycostem, GPB Scientific, Gravitas Biomanufacturing, H.C. Wainwright, Harvard University, Healios K.K., HighCape Partners, Histogenics, Hitachi Chemical, Holland & Knight, Homology Medicines, Hospital Israelita Albert Einstein, Human BioMolecular Research Institute, Human Longevity, Hybrid Concepts International, ICS – AmerisourceBergen, Informa, Innovative Blood Resources, Inotek Pharmaceuticals, Institute for Clinical and Economic Review (ICER), Institute for Genomic Medicine, Integrium, Intellectual Ventures, Intellia Therapeutics, International Institute for the Advancement of Medicine (IIAM), International Society for Cellular Therapy (ISCT), International Society for Stem Cell Research (ISSCR), Invetech, Invitae, Irvine Scientific, Itochu Chemical Frontier Corporation, Janssen R&D, jCyte, Jim Cross, MD Consulting, Johnson & Johnson, Juno Therapeutics, Juventas Therapeutics, Kawasaki Heavy Industries, KBI Biopharma, Kissei America, Kite Pharma, Kyoto University, La Jolla Institute for Allergy and Immunology, Lake Street Capital Markets, LifeSci Capital, LogicBio Therapeutics, Loma Linda University, Longeveron, Lonza, Lovelace Biomedical, Lowy Medical Research Institute, Lung Institute, Lysogene, MAK-SYSTEM, Mallinckrodt Pharmaceuticals, MaSTherCell, MaxCyte, Mayo Clinic, McKesson Specialty Health, MedCision, Medeor Therapeutics, Medical Metrics, MEDINET, MEDIPOST America, Medivate Partners, Medpace, MedPOINT Management, Medtronic, Mesoblast, Mill Creek Life Sciences, MilliporeSigma, MiMedx Group, Ministry of Economy, Trade and Industry (METI), Ministry of Health, Labour and Welfare (MHLW), Miromatrix Medical, Missouri Cures, MolMed, Myonexus Therapeutics, Nant Capital, National Disease Research Interchange, National Institutes of Health (NIH), National Marrow Donor Program – Be The Match, National Search Associates, National University, NDA Advisory Services, Nelsen Biomedical, New York Blood Center, New York Stem Cell Foundation, Nikon Cell Innovation, Nohla Therapeutics, Novadip Biosciences, Novartis Pharmceuti-cals, Novasep, NSVascular, NuTech Medical, Oklahoma Blood Institute, Olympus Corporation, Ono Pharmaceutical, Opsis Therapeu-tics, Opus Biotech Communications, Orange County Business Journal, Orbsen Therapeutics, Orchard Therapeutics, Organovo, ORIG3N, Osiris Therapeutics, Oxford BioMedica, Pall Life Sciences, PCT - Hitachi Chemical Advanced Therapeutics Solutions, PDC*line Pharma, Pepper Hamilton, PersImmune, Pfizer, Phacilitate, PharmaCell, Pharmaceuticals and Medical Devices Agency (PMDA), PMI Preclinical, POC Clinical Research, Precision BioSciences, Prevail Partners, Promethera Biosciences, Propagenix, Qiming Venture Partners, Quad Technologies, Quick – Specialized Healthcare Logistics, QuintilesIMS, Regenerex, Regeneron Pharmaceuticals, RegenMed Systems, REGENXBIO, ReNeuron, Renova Therapeutics, ReproCELL, Rocket Pharma, Rohto Pharmaceutical, RoosterBio, Roslin Cell Therapies, RTW Investments, RxGen, Salk Institute for Biological Studies, San Diego State University, San Diego Zoo Institute for Conservation Research, San Raffaele Telethon Institute for Gene Therapy, SanBio, Sanford Burnham Prebys Medical Discovery Institute, Sanford Consortium for Regenerative Medicine, Sanford Stem Cell Clinical Center at UC San Diego Health, Sangamo Therapeutics, Sanofi, Santa Fe Christian School, Santen, Sapporo Medical University, Sartorius Stedim Biotech, SAVSU Technologies, Schulman IRB, Scinogy, SCM Lifescience, Scottish Development International, SCRIP Intelligence / The Pink Sheet, Secerna, Semma Therapeutics, SENS Research Foundation, Sentien Biotechnologies, SERVA Electrophoresis, Shire, Sigilon Therapeu-tics, Sistemic Limited, SL BIGEN, Soseki CVC, Southland Corporation, Spark Therapeutics, StemBios Technologies, StemBioSys, Stemcell Technology, Steminent Biotherapeutics, StemoniX, Sumitomo Dainippon Pharma, SUNY Downstate, Supporting Science, Switch Bio, Synpromics, Takeda Pharmaceutical Company, Terumo BCT, Tessa Therapeutics, Texas Biomedical Research Institute, The Japanese Society for Regenerative Medicine, The San Diego Union Tribune, The Scripps Research Institute, Thermo Fisher Scientific, ThinkCyte, TiGenix, Tolley Health Economics, TrakCel, Triumvira Immunologics, Tucson Medical Center, Tulane University, TxCell, UC Berkeley, UC Irvine, UC San Diego, UCLA, UK Department for International Trade, uniQure, United National Corporation, Universal Cells, University of Arizona, University of Massachusetts, University of Michigan Health System, University of Notre Dame, University of Oklahoma, University of Oxford, University of Pennsylvania, University of Southern California, US Army Institute of Surgical Research, U.S. Food and Drug Administration, Utah State University, Vericel, VeriGraft, Versant Ventures, Versiti, ViaCyte, Vineti, VitaCyte, Vivet Therapeutics, Voisin Consulting Life Sciences, Voyager Therapeutics, W.L. Gore & Associates, Weill Cornell Medicine, Weizmann Institute of Science, White Star Consulting, WindMIL Therapeutics, WIRB-Copernicus Group, World Courier, WuXi AppTec, Wyss Institute, Xenco Medical, Xintela, Yale School of Medicine, YposKesi,

2017 Sponsors 2017 Presenting Companies

Sponsorship Benefits Platinum Gold Silver + Suite Silver Bronze

Full Conference Registration PassesPartnering Forum - October 3-4Evening Gala Reception - October 3Public Forum & Evening Reception - October 4Scientific Symposium - October 5

8 6 4 4 2

Private Partnering Room at Partnering Forum x x

Hotel Suite for Partnering at Partnering Forum x

Printed Program Advertisement Full page Half page

Partnering Forum Table Top DisplayPlacement determined by level and years of sponsorship x x x x

Scientific Symposium Table Top Display First come, first serve due to limited availability

x x x x

Discounted Rate for Additional Attendance Passes x x x x x

Early Access to Book Hotel Rooms at EstanciaApplicable only until June 1 - then open to public x x x x x

Logo, Description and Link on Marketing MaterialsHome and Sponsor Pages CGMOM Website, Printed Programs, Onsite Signage, Looping PPTs

x x x x x

• Exclusive Partnering Forum Wifi Sponsor• Exclusive Padfolio/Bag Sponsor• Exclusive Lanyard Sponsor

Choose 1

• Gala Reception Co-Sponsor (two available)

• Exclusive Hotel Key Card Sponsor• Ballroom Name Sponsor (two available)

• Partnering Forum Panel Sponsor (inquire for info)

• Morning Workshop Co-Sponsor (inquire for info)

• Private Luncheon Sponsor• Private ARM Member Dinner Sponsor• Private Science Dinner Sponsor• Branded Charging Station Sponsor• Exclusive Online Registration Page Sponsor

Choose 1

• Half-Page Program Ad (multiple available)

• Public Forum & Reception Sponsor• Partnering System Co-Sponsor• Hotel Shuttle Bus Co-Sponsor• Daily Breakfast Sponsor (three available)

• Daily Lunch Sponsor (three available)

• Break Co-Sponsor (two available)

• SS Poster Session or Keynote Sponsor• Collateral Sponsors (one item per sponsor - pens, flash-

drives, mints, microphone, luggage tags, etc.)

• Patient Attendee Sponsor (multiple available)

Choose 1 Choose 1

2018 Sponsorship Opportunity Overview

$30,000 $20,000 $15,000 $10,000 $5,000

Laura ParsonsSenior Director, Marketing & EventsAlliance for Regenerative Medicine525 Second Street, NEWashington, DC 20002Phone: 208-841-4334lparsons@alliancerm.org

Sponsor Contact:

About the Organizers

The Alliance for Regenerative Medicine (ARM) is an international multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving ad-vances in regenerative medicine worldwide. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations. Prior to the formation of ARM in 2009, there was no advocacy organization operating in Washington, D.C. to specifically represent the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today, ARM has more than 270 members and is the leading global advocacy organiza-tion in this field.

The Sanford Stem Cell Clinical Center at UC San Diego Health exists to transform the enormous potential of stem cell science into real therapies for patients. Our goal is to advance therapies and cures by supporting ethically conducted clinical trials that result from scientific discoveries. The Sanford Stem Cell Clinical Center was created to protect and counsel patients, and accelerate innovative stem cell research into patient diagnos-tics and therapy. As the center’s clinical arm, the CIRM Alpha Stem Cell Clinic at UC San Diego Health works to accelerate the design of innovative stem cell research to advance the testing and delivery of safe and effective stem cell-based therapies in regenerative medicine. Our current clinical trials focus on diabetes, spinal cord injuries, heart problems and cancer.

www.stemcellmeetingonthemesa.comwww.meetingonthemesa.com